Isorhapontigenin delays senescence and matrix degradation of nucleus pulposus cells via PI3K/AKT/mTOR-mediated autophagy pathway in vitro and alleviates intervertebral disc degeneration in vivo
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.112717 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Ze Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, …. Hauptthemen laut MEDLINE: Intervertebral Disc Degeneration, Nucleus Pulposus, TOR Serine-Threonine Kinases, Autophagy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Wenzhou Municipal Science and Technology Bureau.
Abstract (Originalsprache)
Intervertebral disc degeneration (IVDD), a common degenerative disc disease, is a major etiological factor for back pain, affecting a significant number of middle-aged and elderly individuals worldwide. Thus, IVDD is a major socio-economic burden. The factors contributing to the complex IVDD etiology, which has not been elucidated, include inflammation, oxidative stress, and natural aging. In particular, inflammation and aging of nucleus pulposus cells are considered primary pathogenic factors. Isorhapontigenin (ISO) is a polyphenolic compound commonly found in traditional Chinese herbs and grapes. We have demonstrated that ISO exerts anti-inflammatory and anti-aging effects and mitigates extracellular matrix (ECM) degradation. In this study, in vitro experiments revealed that, ISO delays aging and ECM degradation by promoting PI3K/AKT/mTOR-mediated autophagy. Meanwhile, in vivo experiments affirmed that ISO delays the progression of IVDD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, Z…
- Aksu District People's Hospital, Aksu, Xinjiang, China.
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; The Second School of Medicine, Wenzhou Medical University, Wenz…
- Aksu District People's Hospital, Aksu, Xinjiang, China. Electronic address: gexinjiang2003@163.com.
Förderung
- Wenzhou Municipal Science and Technology Bureau
Zitieren
APA
Wang, Z., Ma, J., Sun, Y., Jin, Z., Zheng, R., Li, Y., Yu, H., Ye, H., Wu, Y., Ge, X., & Chen, Z. (2024). Isorhapontigenin delays senescence and matrix degradation of nucleus pulposus cells via PI3K/AKT/mTOR-mediated autophagy pathway in vitro and alleviates intervertebral disc degeneration in vivo. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112717
Vancouver
Wang Z, Ma J, Sun Y, Jin Z, Zheng R, Li Y, et al. Isorhapontigenin delays senescence and matrix degradation of nucleus pulposus cells via PI3K/AKT/mTOR-mediated autophagy pathway in vitro and alleviates intervertebral disc degeneration in vivo. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112717
BibTeX
@article{Wang2024,
author = {Wang, Ze and Ma, Jiawei and Sun, Yun and Jin, Zebin and Zheng, Rukang and Li, Yuanyuan and Yu, Heng and Ye, Haobo and Wu, Yaosen and Ge, Xinjiang and Chen, Zexin},
title = {Isorhapontigenin delays senescence and matrix degradation of nucleus pulposus cells via PI3K/AKT/mTOR-mediated autophagy pathway in vitro and alleviates intervertebral disc degeneration in vivo},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.112717}
}
EUVIMED